Efficacy and safety of Y-3 intracalvariosseous injection versus intravenous injection in the treatment of acute large hemispheric infarction (SOLUTION-2): rationale and design of a multicentre, prospective, randomised, open-label, blind endpoint (PROBE) trial.
- DOI
- 10.1136/svn-2024-004011
- Published
- 2026 Mar 4
- Container
- Stroke and vascular neurology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1136/svn-2024-004011,
title = {Efficacy and safety of Y-3 intracalvariosseous injection versus intravenous injection in the treatment of acute large hemispheric infarction (SOLUTION-2): rationale and design of a multicentre, prospective, randomised, open-label, blind endpoint (PROBE) trial.},
author = {Wang N and Zhang M and Yang M and Liu W and Liu W and Ou Y and Zhou M and Wang X and Sun Z and Pan Y and Wang Y and Wang Y},
year = {2026},
journal = {Stroke and vascular neurology},
doi = {10.1136/svn-2024-004011},
url = {https://doi.org/10.1136/svn-2024-004011}
}RIS
TY - JOUR TI - Efficacy and safety of Y-3 intracalvariosseous injection versus intravenous injection in the treatment of acute large hemispheric infarction (SOLUTION-2): rationale and design of a multicentre, prospective, randomised, open-label, blind endpoint (PROBE) trial. AU - Wang N AU - Zhang M AU - Yang M AU - Liu W AU - Liu W AU - Ou Y AU - Zhou M AU - Wang X AU - Sun Z AU - Pan Y AU - Wang Y AU - Wang Y PY - 2026 JO - Stroke and vascular neurology DO - 10.1136/svn-2024-004011 UR - https://doi.org/10.1136/svn-2024-004011 ER -
APA
N, W., M, Z., M, Y., W, L., W, L., Y, O., M, Z., X, W., Z, S., Y, P., Y, W., & Y, W. (2026). Efficacy and safety of Y-3 intracalvariosseous injection versus intravenous injection in the treatment of acute large hemispheric infarction (SOLUTION-2): rationale and design of a multicentre, prospective, randomised, open-label, blind endpoint (PROBE) trial.. Stroke and vascular neurology. https://doi.org/10.1136/svn-2024-004011
Source records
- pubmed · retrieved 2026-09-25T22:27:52.068Z